News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,266 Results
Type
Article (87993)
Company Profile (825)
Press Release (781429)
Multimedia
Podcasts (196)
Webinars (28)
Section
Business (233274)
Career Advice (4147)
Deals (39883)
Drug Delivery (151)
Drug Development (91424)
Employer Resources (205)
FDA (18395)
Job Trends (17428)
News (397942)
Policy (39970)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (148)
Alliances (56981)
ALS (181)
Alzheimer's disease (1792)
Antibody-drug conjugate (ADC) (346)
Approvals (18575)
Artificial intelligence (626)
Autoimmune disease (162)
Automation (36)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (203)
Biotechnology (490)
Bladder cancer (163)
Brain cancer (65)
Breast cancer (663)
Cancer (5042)
Cardiovascular disease (444)
Career advice (3570)
Career pathing (41)
CAR-T (303)
CDC (59)
Celiac Disease (2)
Cell therapy (826)
Cervical cancer (37)
Clinical research (77035)
Collaboration (1822)
Company closure (5)
Compensation (1155)
Complete response letters (73)
COVID-19 (2992)
CRISPR (99)
C-suite (865)
Cystic fibrosis (154)
Data (6274)
Decentralized trials (2)
Denatured (72)
Depression (151)
Diabetes (532)
Diagnostics (7230)
Digital health (47)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (302)
Drug pricing (224)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100147)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135077)
Executive appointments (1033)
FDA (21579)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1556)
Gene editing (215)
Generative AI (64)
Gene therapy (671)
GLP-1 (1127)
Government (5441)
Grass and pollen (8)
Guidances (385)
Healthcare (20946)
HIV (60)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (292)
Immuno-oncology (59)
Indications (99)
Infectious disease (3279)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (120)
Intellectual property (248)
Interviews (816)
IPO (17955)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (69)
Kidney cancer (17)
Labor market (93)
Layoffs (660)
Leadership (40)
Legal (10160)
Liver cancer (98)
Longevity (16)
Lung cancer (679)
Lymphoma (379)
Machine learning (45)
Management (66)
Manufacturing (855)
MASH (173)
Medical device (15028)
Medtech (15080)
Mergers & acquisitions (22986)
Metabolic disorders (1395)
Multiple sclerosis (163)
NASH (23)
Neurodegenerative disease (355)
Neuropsychiatric disorders (98)
Neuroscience (3115)
Neurotech (1)
NextGen: Class of 2026 (7708)
Non-profit (5112)
Now hiring (66)
Obesity (674)
Opinion (336)
Ovarian cancer (167)
Pain (211)
Pancreatic cancer (231)
Parkinson's disease (301)
Partnered (39)
Patents (511)
Patient recruitment (482)
Peanut (60)
People (66916)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase 1 (23800)
Phase 2 (33426)
Phase 3 (25193)
Pipeline (5073)
Policy (337)
Postmarket research (3554)
Preclinical (10693)
Press Release (72)
Prostate cancer (247)
Psychedelics (55)
Radiopharmaceuticals (301)
Rare diseases (905)
Real estate (7440)
Recruiting (80)
Regulatory (29031)
Reports (67)
Research institute (2725)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (257)
Series B (197)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (113)
Tariffs (101)
The Weekly (122)
Vaccines (1148)
Venture capital (96)
Weight loss (462)
Women's health (88)
Worklife (21)
Date
Today (84)
Last 7 days (555)
Last 30 days (2540)
Last 365 days (32852)
2026 (2577)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (89)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (51564)
Australia (9058)
California (11545)
Canada (3315)
China (1168)
Colorado (488)
Connecticut (500)
Delaware (347)
Europe (118458)
Florida (1691)
Georgia (372)
Hawaii (4)
Idaho (68)
Illinois (965)
India (68)
Indiana (543)
Iowa (24)
Japan (429)
Kansas (133)
Kentucky (43)
Louisiana (29)
Maine (83)
Maryland (1457)
Massachusetts (8495)
Michigan (358)
Minnesota (665)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (86)
New Jersey (3108)
New Mexico (33)
New York (3048)
North Carolina (1611)
North Dakota (10)
Northern California (5520)
Ohio (354)
Oklahoma (22)
Oregon (55)
Pennsylvania (2312)
Puerto Rico (23)
Rhode Island (50)
South America (1661)
South Carolina (65)
South Dakota (1)
Southern California (4458)
Tennessee (177)
Texas (1822)
United States (41655)
Utah (346)
Vermont (1)
Virginia (290)
Washington D.C. (88)
Washington State (972)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
There are 870,266 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
BioNTech’s Multi-Modality Play Outpaces Moderna’s mRNA-Focused Pipeline
After advancing in lockstep through the pandemic, the fortunes of the biotechs have diverged as their use of COVID-19 windfalls has taken shape.
February 3, 2026
·
5 min read
·
Nick Paul Taylor
Manufacturing
As Amgen and Lilly Recommit, Puerto Rico Seeks To Regain Manufacturing Momentum
After suffering in the wake of expired tax incentives for pharmas, the island is trying to take advantage of geopolitics to grow its drug manufacturing sector.
February 3, 2026
·
4 min read
·
Nick Paul Taylor
Press Releases
Sharp Therapeutics Announces Private Placement of up to US$3.0 Million in Unsecured Convertible Notes
February 2, 2026
·
6 min read
Wave To Work Alone on RNA Editor as AATD Picture Becomes Clearer
After GSK’s return of Wave Life Sciences’ WVE-006 as well as the mid-stage failure of Korro Bio’s candidate, the alpha-1 antitrypsin deficiency landscape is coming into focus, with Wave and Beam Therapeutics leading the way.
February 2, 2026
·
3 min read
·
Heather McKenzie
Press Releases
TempraMed Enters Strategic Media Partnership with Dr. Phil’s Envoy Media, Validating Product Portfolio and Accelerating Market Adoption Across the United States
Access to an audience of over 19 million individuals monthly will expand national exposure, and supports scalable demand generation across B2C and B2B channels for TempraMed’s full product portfolio
February 2, 2026
·
6 min read
Press Releases
Theralase(R) Completes Enrollment in Bladder Cancer Clinical Study
February 2, 2026
·
7 min read
Press Releases
OS Therapies Initiates US FDA BLA Filing for OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
February 2, 2026
·
6 min read
Press Releases
Aires Enters Collaboration Agreement with Leading Wellness Expert Gary Brecka’s Brand, The Ultimate Human
February 2, 2026
·
6 min read
Press Releases
PharmaTher Launches Strategic Initiative to Pursue Health Canada Approval for Generic Semaglutide in Canada, Building on FDA-Approved Ketamine Success
February 2, 2026
·
4 min read
Press Releases
CD Genomics Launches Microbial Single-Cell Sequencing Service, Emerging as One of the Few Providers Capable of Unlocking “Microbial Dark Matter”
February 2, 2026
·
1 min read
1 of 87,027
Next
